The case for PED's primacy. PED is the only elasticity that directly determines whether a change in a firm's own price raises or lowers its total revenue — the quantity the firm most immediately controls. Where ∣PED∣>1 (elastic), a price rise lowers TR and a price cut raises it; where ∣PED∣<1 (inelastic), the reverse holds; at ∣PED∣=1, TR is at its maximum (LO 2.2.7, LO 2.2.5). A firm that ignores PED can systematically mis-set price in a direction that lowers revenue — the single most costly mistake in product pricing. A firm's PED estimate also carries practical implications for where on the straight-line demand curve to operate: moving towards the midpoint raises TR regardless of the direction of travel. On this reasoning PED is the central consideration.
The case against — other considerations. Three material qualifications apply.
First, profit depends on costs, not only revenue. A profit-maximising firm equates marginal revenue with marginal cost. The PED-maximising revenue point is not the profit-maximising point unless marginal cost is zero. For a product with high and rising marginal costs — e.g. a hand-crafted item — the price that maximises profit may lie well above the PED-based revenue maximum.
Second, YED and XED matter alongside PED. If disposable incomes are rising rapidly and the product has a high positive YED (a normal luxury, ∣YED∣>1), the firm can expect volume growth over the medium run without a price cut — holding price captures the income-driven volume. If XED to a leading rival is strongly positive (close substitute, ∣XED∣ well above 0), the firm's own PED is partly a reflection of rival pricing; strategic responses to competitors can dominate PED signals in the short run.
Third, firm objectives are not always short-run revenue maximisation. A firm using penetration pricing to build market share deliberately sets price below the PED-maximising point to drive volume and lock in customers. A loss-leader (sold near or below cost to draw shoppers in) is priced on strategic grounds, not elasticity. New-product launches often price for information gathering rather than for immediate TR maximisation. In each of these cases, PED remains relevant but is not the dominant input.
Fourth, PED estimates are themselves data-limited: they are typically ceteris paribus estimates at the current price, and change over time as consumers acquire information and adjust habits (LO 2.2.6, factor 'time'). A firm that treats a single PED number as a fixed constant will mis-set price in the long run.
Reasoned judgement. PED is a necessary consideration — ignoring it causes systematic pricing error — but is not sufficient to determine optimal price. Its weight relative to YED, XED, costs and strategic objectives depends on the firm's circumstances. In a mature market with stable incomes and the firm maximising current revenue, PED dominates: the firm should set price near the midpoint of its demand curve where ∣PED∣=1. In a growing market with rising incomes, YED matters at least as much as PED, because volume will grow with income and premature price cuts throw away margin. In strategic phases (launch, defence against a rival, loss-leader deployment), objectives dominate and PED is simply one input to that strategic calculation. The strongest statement is therefore: PED is the most important revenue-direction consideration but not necessarily the most important pricing consideration — the pricing problem requires PED alongside YED, XED, costs and strategic objectives, with the relative weights shifting across contexts.